Vanda Pharmaceuticals (VNDA) surges 20% in premarket trading after Cycle Pharmaceuticals reaffirms $8/share all cash offer in ...

The Indian pharma market grew 5.1 per cent (year-on-year) in September, led by cardiac, dermal and anti-diabetic therapies, a ...

In less than a month, Americans will head to the polls—or vote by mail—and elect the next president of the U.S. | While a ...

Earlier this year, Evonik unveiled a restructuring project that will result in up to 2,000 layoffs. | After Evonik in March ...

Adam Wandt, an attorney and deputy chair for technology at the John Jay School of Criminal Justice, said the barrage of state ...

Pharma Solutions will demonstrate the critical role of excipients in drug formulation by showcasing breakthrough research at ...

The Danish Medicines Council forecasts processing times for treatment evaluations will rise from 19 to 27 weeks by Q1 2025 ...

Swoop, the leader in privacy-safe healthcare marketing and data solutions, is proud to announce the launch of Swoop AI ...

Turnstone Biologics (Nasdaq: TSBX) is restructuring operations, cutting 60% of its workforce to focus on its lead program, ...

After spying blockbuster potential in Longboard Pharmaceuticals’ epilepsy med, brain disease-focused pharma Lundbeck is ...

(RTTNews) - BioCryst Pharmaceuticals, Inc. (BCRX) Monday announced new data from an analysis of U.S. claims data of patients with hereditary angioedema (HAE).

The research, compiled by the European Social Insurance Platform (ESIP) and the Medicine Evaluation Committee (MEDEV) and ...